# Splanchnic Venous Capacitance in Postural Tachycardia Syndrome

> **NCT05375968** · PHASE2 · RECRUITING · sponsor: **Vanderbilt University Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Postural Tachycardia Syndrome (POTS)

## Interventions

- **DIAGNOSTIC_TEST:** Measurement of Splanchnic venous capacitance(SVC)done at Baseline and after 90 min of 75 g glucose in Healthy Controls POTS patients
- **DIAGNOSTIC_TEST:** Measurement of Splanchnic venous capacitance(SVC)done at Baseline and after 90 min of 75 g glucose in Healthy Controls
- **DRUG:** Compare change is SVC and SMA flow due to GIP antagonist GIP(3-30)NH2
- **DRUG:** Compare change is SVC and SMA flow due to saline

## Key facts

- **NCT ID:** NCT05375968
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-25
- **Primary completion:** 2027-05-31
- **Final completion:** 2028-06-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05375968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05375968, "Splanchnic Venous Capacitance in Postural Tachycardia Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05375968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*